Benitec Biopharma (BNTC) Research & Development (2019 - 2025)
Benitec Biopharma (BNTC) has disclosed Research & Development for 7 consecutive years, with $17.5 million as the latest value for Q2 2025.
- Quarterly Research & Development rose 398.41% to $17.5 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $27.9 million through Jun 2025, up 78.72% year-over-year, with the annual reading at $18.3 million for FY2025, 17.45% up from the prior year.
- Research & Development hit $17.5 million in Q2 2025 for Benitec Biopharma, up from $6.5 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $17.5 million in Q2 2025 to a low of $313000.0 in Q4 2024.
- Historically, Research & Development has averaged $4.0 million across 5 years, with a median of $3.2 million in 2022.
- Biggest five-year swings in Research & Development: crashed 93.87% in 2024 and later skyrocketed 398.41% in 2025.
- Year by year, Research & Development stood at $3.1 million in 2021, then grew by 19.55% to $3.8 million in 2022, then skyrocketed by 35.66% to $5.1 million in 2023, then plummeted by 93.87% to $313000.0 in 2024, then skyrocketed by 5492.33% to $17.5 million in 2025.
- Business Quant data shows Research & Development for BNTC at $17.5 million in Q2 2025, $6.5 million in Q1 2025, and $313000.0 in Q4 2024.